CRISPR Therapeutics AG (CRSP)
53.90
+0.17
(+0.32%)
USD |
NASDAQ |
Apr 26, 16:00
53.56
-0.34
(-0.63%)
After-Hours: 16:40
CRISPR Therapeutics Price to Book Value: 2.430 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 2.422 |
| April 24, 2024 | 2.509 |
| April 23, 2024 | 2.543 |
| April 22, 2024 | 2.509 |
| April 19, 2024 | 2.482 |
| April 18, 2024 | 2.532 |
| April 17, 2024 | 2.505 |
| April 16, 2024 | 2.613 |
| April 15, 2024 | 2.647 |
| April 12, 2024 | 2.735 |
| April 11, 2024 | 2.836 |
| April 10, 2024 | 2.783 |
| April 09, 2024 | 2.939 |
| April 08, 2024 | 2.889 |
| April 05, 2024 | 2.831 |
| April 04, 2024 | 2.928 |
| April 03, 2024 | 2.908 |
| April 02, 2024 | 2.927 |
| April 01, 2024 | 3.069 |
| March 28, 2024 | 3.068 |
| March 27, 2024 | 3.158 |
| March 26, 2024 | 3.194 |
| March 25, 2024 | 3.199 |
| March 22, 2024 | 3.223 |
| March 21, 2024 | 3.353 |
| Date | Value |
|---|---|
| March 20, 2024 | 3.283 |
| March 19, 2024 | 3.239 |
| March 18, 2024 | 3.217 |
| March 15, 2024 | 3.284 |
| March 14, 2024 | 3.070 |
| March 13, 2024 | 3.188 |
| March 12, 2024 | 3.210 |
| March 11, 2024 | 3.275 |
| March 08, 2024 | 3.365 |
| March 07, 2024 | 3.384 |
| March 06, 2024 | 3.446 |
| March 05, 2024 | 3.453 |
| March 04, 2024 | 3.485 |
| March 01, 2024 | 3.571 |
| February 29, 2024 | 3.591 |
| February 28, 2024 | 3.738 |
| February 27, 2024 | 3.800 |
| February 26, 2024 | 3.669 |
| February 23, 2024 | 3.581 |
| February 22, 2024 | 3.675 |
| February 21, 2024 | 3.514 |
| February 20, 2024 | 3.357 |
| February 16, 2024 | 3.506 |
| February 15, 2024 | 3.592 |
| February 14, 2024 | 3.360 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.492
Minimum
May 09 2022
9.329
Maximum
Jan 14 2021
3.859
Average
3.163
Median
Price to Book Value Benchmarks
| Vertex Pharmaceuticals Inc | 5.839 |
| Intellia Therapeutics Inc | 1.901 |
| Novartis AG | 5.012 |
| Verve Therapeutics Inc | 0.8585 |
| AC Immune SA | 1.215 |
Price to Book Value Related Metrics
| Price | 53.90 |
| Earnings Yield | -3.58% |
| Market Cap | 4.575B |